Drugs / TSN2898
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02796066 | Jun 2016 → Feb 2017 | acne | Thesan Pharmaceuticals, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TSN2898 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02796066 ↗ |
| Action | Inhibit | “TSN2898 is an inhibitor of stearoyl-CoA desaturase-1 (SCD-1)” NCT02796066 ↗ |
| Route | Topical | “TSN2898 topical gel and matched gel vehicle, applied daily on the face” NCT02796066 ↗ |
| Target | SCD | “inhibitor of stearoyl-CoA desaturase-1 (SCD-1)” NCT02796066 ↗ |